@pfeifer1982
Yet another thoroughly comprehensive review, thank you. My only query would be:
Regarding the patent-pending from 2020, surely this would have been provided in the second BLA submission last year, since it appears to meet a reasonable hypothesis of MoA, right? If not, then questions must be asked as to what MSB's management are/were doing.
So if the FDA have already assessed it as a part of the approval process of Ryoncil, then I keep coming back to the key factor for Ryoncil's approval being the FDA's assessment of the adequacy of the P3 trial. Again, what has made them backflip here?
- Forums
- ASX - By Stock
- Ann: Investor Presentation
@pfeifer1982Yet another thoroughly comprehensive review, thank...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
|
|||||
Last
24.0¢ |
Change
-0.040(14.3%) |
Mkt cap ! $43.11M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 24.0¢ | $136.0K | 544.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 446 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.245 |
1 | 23842 | 0.240 |
3 | 100000 | 0.235 |
2 | 12173 | 0.230 |
1 | 3334 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 446 | 1 |
0.255 | 5000 | 1 |
0.260 | 205000 | 2 |
0.265 | 10000 | 1 |
0.270 | 10000 | 1 |
Last trade - 15.59pm 20/06/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Chairman
Nick Poll
Executive Chairman
Previous Video
Next Video
SPONSORED BY The Market Online